The 20/21 organising committee would like to say a final thank you to the over 300 attendees and speakers who contributed to a wonderful #ICHS2021 online. Remember your login is still valid for another 3 months to view recordings. Until next year!! #ICHSBASEL2022
Thanks to our Sponsors Gilead, Pfizer, MSD, F2G, Cidara, Kyorin, Ansun, NIH, Mayne Pharma, Amplyx and the Worldide Institute of Medical Education without whom we could not have hosted this meeting #ICHS2021
Especial thank you to our conference organiser ICMS https://t.co/4PLwLYRbf1 for being so flexible in pivoting from an in person to virtual platform and bringing this meeting together for us.
Can't wait to see you in Basel for ICHS2022
What a fantastic 3 days for #ICHS2021. While we were so very disappointed to not be able to see you all in person we are nevertheless delighted that we could meet in this virtual forum. We wish to thank you all; delegates, speakers, chairs,
for your enthusiastic participation in our meeting and hope that you will remain a member of the ICHS society and keep this conversation going https://t.co/liE8dkdJuH .
Recording now available for Professor Georgios Chamilos' talk on Small molecule inhibitors/TKI in the 18/2/21 morning symposium New cancer therapies and risk for infection #ICHS2021
WIME Q&A with Professor Dimitrios Kontoyiannis, Dr Issam Raad and Prof Monica Slavin at 3.10 -3.20 AEST today. Catch up from yesterday on the Texas storm event. #ICHS2021
@brendanmcID @DavidAguileraAl@NCICancer Recordings will be available to ICHS members for three months post event. Consider a membership https://t.co/U2SG9DM0XF
Abstract submissions close TODAY for @ASIDANZ virtual ASM 2021 #ASID21 in March. Submit an abstract: https://t.co/k5GJXr2WAj
Program: https://t.co/ARes9OcHGg
Join us after the break for what promise to be another two great symposia- regional directions in ICH with Louis Chai, Yae-Jean Kim and Tan Ban Hock or fungal infections and future directions (INFOCUS) with Maria Gonzalez-Lara, Arnaldo Colombo and Dimitrios Kontoyiannis #ICHS2021
@ASIDANZ#ASID21 detailed program released! Features local and international #InfectiousDiseases experts. Read: https://t.co/ARes9OcHGg
Registrations close tomorrow: https://t.co/frX5iLGF5e
Thank you again today to all our presenters, delegates and chairs for an action packed program! Two giants of TDM with Professor William Hope presenting and Prof Jason Roberts chairing this evenings/mornings Plenary. #ICHS2021
Good luck to all our best abstract finalists Dr Johan Maertens Dr Chikara Ogimi Dr Zaid Haddadin Dr Brad Gardiner Dr Abby Douglas. The winner will be announced at the closing ceremony tommorrow. #ICHS2021
We hope you are enjoying the poster session! Join us at 2 to hear from the best of the best- top 5 abstracts chosen from the poster submissions. Winners of the top 5, and best poster will be announced at the closing ceremony. #ICHS2021
We are receiving feedback that the live Q and A is being glitchy. We are working on the problem. Please continue to submit your questions, they are being recorded. Seems like a good opportunity to take advantage of the meeting hub to initiate discussions on burning questions!
Four excellent sessions again this morning. Join us back after the break for the Pfizer sponsored Symposia: Antimicrobial Resistance in Emerging Fungal Pathogens - Lessons from recent real World yeast and mould clinical cases. Please visit the Virtual exhibition in the meantime!
Which will you choose Stream 1: Microbiome with Dr Markey and Prof Jay Fishman or stream 2: tough viruses and new tx with @FranciscoMarty_ Dr Papanicolaou and Prof Roy Chemaly? Don't forget you can always watch the recordings and chat in the hub at any time! #ICHS2021
Check back later today for a recording of Professor Georgios Chamilos presentation "Small molecule inhibitors/TKI" and be sure to connect in the meeting hub
Technical delays to start the day but we are now LIVE with Professor Vicki Morrison "Spectrum and prophylaxis of infectious complications associated with monoclonal and bi-specific antibody therapy" in Stream 2 Symposium: New cancer therapies and risk for infection